- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about mRNA
Recent news which mentions mRNA
Tradepulse Power Inflow Alert: Moderna Inc. Rises 8.9% On The Trading Day
September 13, 2024
Tickers
MRNA
From Benzinga
Should You Buy Novavax Stock After This Regulatory Win?
September 13, 2024
From Motley Fool
A Bull Market Is Here: 2 High-Potential Stocks Down More Than 50% to Buy Right Now
September 13, 2024
From Motley Fool
From Benzinga
Why Are Novavax Shares Trading Lower Today?
September 12, 2024
From Benzinga
Stocks Edge Up As Producer Inflation Supports Rate Cut Bets, Small Caps, Miners Rally: What's Driving Markets Thursday?
September 12, 2024
From Benzinga
Moderna Outlines Post-Covid Roadmap, Cuts Research Budget, Forecasts 2025 Sales Below Expectations
September 12, 2024
From Benzinga
Nasdaq, S&P 500 Set For Modest Gains As Investors Eye August Inflation Data And ECB Rate Decision
September 12, 2024
From Benzinga
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
September 12, 2024
From Motley Fool
GSK Halts Herpes Simplex Virus Vaccine Development, Clears Path For Other Contenders Like Moderna, BioNTech
September 11, 2024
From Benzinga
Is Hims & Hers Health the Next Teladoc?
September 11, 2024
From Motley Fool
Wall Street Rallies After Last Week's Sell-Off, Palantir Soars On S&P 500 Inclusion, Airlines Rally: What's Driving Markets Monday?
September 09, 2024
From Benzinga
Why Is Moderna Stock Trading Higher On Monday?
September 09, 2024
From Benzinga
Intel, Moderna And Dollar General Were Among Top 10 Large Cap Losers In August: Are The Others In Your Portfolio?
September 08, 2024
From Benzinga
Is It Time to Buy August's Worst-Performing Nasdaq Stocks?
September 07, 2024
From Motley Fool
Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows
September 06, 2024
From Benzinga
Jim Cramer: Oklo Is Losing Money 'Hand-Over-Fist,' But This Private Equity Stock Is A Buy
September 05, 2024
From Benzinga
Is It Time to Buy August's Worst-Performing S&P 500 Stocks?
September 04, 2024
From Motley Fool
UK, Taiwan Approve Moderna's Updated COVID-19 Shot
September 03, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 03, 2024
From Benzinga
Magnificent 7 Miss Out, 2 Cybersecurity Stocks Stand Firm, Retailers Lag In Volatile August: Here Are The Top S&P 500 Gainers And Losers
August 31, 2024
From Benzinga
Moderna And BioNTech Bet On Personalized Cancer Vaccines To Revive Fortunes After Dwindling COVID-19 Vaccine Sales
August 29, 2024
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.